bioRxiv Science⌕ Search
Home/Archive/bioRxiv

bioRxiv · 10.1101/2022.01.22.477353

Towards the identification and optimization of the "dose-response" relationship of transcranial direct current stimulation

Salvador, R.·Biagi, M. C.·Perez Pelegri, M.·Zhou, J.·Travison, T.·Alvaro Pascual-Leone, A.·Manor, B.·Ruffini, G.
View original source ↗Export metadata ↓

Abstract

Transcranial direct current stimulation (tDCS) is being investigated as a therapeutic tool in several neuropsychiatric disorders, but its mechanisms of action remain incompletely understood and its effectiveness is highly variable from subject to subject. Some of this inter-subject variance is thought to stem from individual differences in head anatomy, which result in different electric field distributions across individuals for the same stimulation settings. In a recent block-randomized, sham-controlled pilot study, 18 older adults with mild-to-moderate motor and cognitive impairments underwent a 2-week, 10-session intervention of 2 mA bipolar tDCS with the anode over the left dorsolateral prefrontal cortex (DLPFC) and cathode over the right supraorbital region (anodal F3 vs. FP2 using sponge electrodes in the 10-20 EEG system). tDCS, compared to sham stimulation, improved average cognitive-motor performance over a two-week follow-up. For a subset of 12 participants from this cohort who underwent structural brain MRIs at baseline, we derived tDCS-induced electric field properties using MRI-derived realistic, individualized finite element modeling. We hypothesized that the electric field component orthogonal (En) to the cortex over the left DLPFC would correlate with observed cognitive-motor improvements. Across the 12 subjects the average tDCS-induced electric field over the target area was highly variable with a standard deviation of the surface average En over the left DLPFC of 21% of the mean. For those subjects who were randomized to tDCS intervention (n=6), those who exhibited greater improvement in cognitive-motor performance were exposed to greater normal component of the tDCS electric field averaged over the left DLPFC (r95 % [isin] [-0.99,-0.59]). In contrast, averaged over the right DLPFC, En was a poor predictor of outcome (r95 % [isin] [-0.08,0.97]), as was the amplitude of the current injected (a widely adopted dosing parameter). In light of these results, we conducted a retrospective modeling experiment using personalized montage optimization algorithms to achieve a desired En amplitude over the left DLPFC. The optimized montages induced an average En on the left DLPFC comparable to the bipolar montages, but with half the variability (standard deviation was 11% compared to 21% with bipolar montages). In addition, these results suggest that optimized multichannel montages afford more focal targeting, with lower "spill-over" of electric field onto other cortical areas. These proof-of-concept results, though based upon a small sample size, indicate that assessment of the E-field distribution is critical when evaluating the effects of tDCS intervention. They also reinforce the importance of controlled cortical electric field dosing in tDCS and the potential advantages of optimized multichannel stimulation. Main findings: O_LIThe lDPFC averaged normal component of the electric field correlated with cognitive-motor improvements following tDCS intervention. C_LIO_LIIn older adults, head and brain anatomical differences resulted in high inter-subject variability of tDCS-induced electric fields. C_LIO_LItDCS montages optimized from modeling and delivered via multichannel electrode arrays can control variance and maximize electric field on target, while minimizing effects elsewhere. C_LI

Explore related subjects

neurosciencePreprint

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Salvador, R., Biagi, M. C., Perez Pelegri, M., Zhou, J., Travison, T., Alvaro Pascual-Leone, A., Manor, B., Ruffini, G.. 2022-01-25. Towards the identification and optimization of the "dose-response" relationship of transcranial direct current stimulation. https://doi.org/10.1101/2022.01.22.477353

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗
bioRxiv2026

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗
bioRxiv2026

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗